FI101296B1 - Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi - Google Patents
Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksiInfo
- Publication number
- FI101296B1 FI101296B1 FI915825A FI915825A FI101296B1 FI 101296 B1 FI101296 B1 FI 101296B1 FI 915825 A FI915825 A FI 915825A FI 915825 A FI915825 A FI 915825A FI 101296 B1 FI101296 B1 FI 101296B1
- Authority
- FI
- Finland
- Prior art keywords
- cyclopentyloxycarbonyl
- methylbenzenesulfonamide
- methoxybenzoyl
- indol
- ylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9027018 | 1990-12-12 | ||
GB909027018A GB9027018D0 (en) | 1990-12-12 | 1990-12-12 | Heterocyclic compounds |
Publications (4)
Publication Number | Publication Date |
---|---|
FI915825A0 FI915825A0 (fi) | 1991-12-11 |
FI915825A FI915825A (fi) | 1992-06-13 |
FI101296B FI101296B (fi) | 1998-05-29 |
FI101296B1 true FI101296B1 (fi) | 1998-05-29 |
Family
ID=10686919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI915825A FI101296B1 (fi) | 1990-12-12 | 1991-12-11 | Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi |
Country Status (28)
Country | Link |
---|---|
US (1) | US5294636A (fi) |
EP (1) | EP0490649B1 (fi) |
JP (1) | JP2650807B2 (fi) |
KR (1) | KR100194479B1 (fi) |
CN (2) | CN1032469C (fi) |
AP (1) | AP286A (fi) |
AT (1) | ATE145199T1 (fi) |
AU (1) | AU656344B2 (fi) |
CA (1) | CA2056067C (fi) |
CZ (1) | CZ288151B6 (fi) |
DE (1) | DE69123123T2 (fi) |
DK (1) | DK0490649T3 (fi) |
ES (1) | ES2094797T3 (fi) |
FI (1) | FI101296B1 (fi) |
GB (2) | GB9027018D0 (fi) |
GR (1) | GR3021605T3 (fi) |
HK (1) | HK81497A (fi) |
HU (2) | HU213109B (fi) |
IE (1) | IE914316A1 (fi) |
IL (1) | IL100090A (fi) |
MX (1) | MX9102475A (fi) |
MY (1) | MY108629A (fi) |
NZ (1) | NZ240940A (fi) |
PH (1) | PH30041A (fi) |
RU (1) | RU2107682C1 (fi) |
SK (1) | SK279018B6 (fi) |
TW (1) | TW222264B (fi) |
ZA (1) | ZA919772B (fi) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0455596B1 (de) * | 1990-05-04 | 1994-11-02 | Novartis AG | Substituierte Indole |
IL100091A (en) * | 1990-12-12 | 1998-08-16 | Zeneca Ltd | Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole) |
GB9119001D0 (en) * | 1991-09-05 | 1991-10-23 | Ici Plc | Pharmaceutical agents |
GR1001368B (el) * | 1992-10-08 | 1993-10-29 | Ici Plc | Φαρμακευτικοί φορείς. |
DE4235133A1 (de) * | 1992-10-19 | 1994-04-21 | Bayer Ag | Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid |
IS1736B (is) | 1993-10-01 | 1999-12-30 | Astra Ab | Aðferð og tæki sem stuðla að aukinni samloðun agna |
DE69429357T2 (de) * | 1993-10-01 | 2002-08-14 | Astrazeneca Ab, Soedertaelje | Verfahren i |
GB9723985D0 (en) | 1997-11-14 | 1998-01-14 | Zeneca Ltd | Pharmaceutical compositions |
GB9726735D0 (en) * | 1997-12-18 | 1998-02-18 | Zeneca Ltd | Pharmaceutical compositions |
IL139243A0 (en) * | 2000-10-24 | 2001-11-25 | Internat Specialty Products Is | Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof |
TWI353979B (en) * | 2002-04-10 | 2011-12-11 | Nippon Zoki Pharmaceutical Co | Novel crystal form of 5-hydroxy-1-methylhydantoin |
US20050026882A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
US20090317476A1 (en) * | 2003-07-31 | 2009-12-24 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
US20050113410A1 (en) * | 2003-11-03 | 2005-05-26 | Mark Tawa | Pharmaceutical salts of zafirlukast |
EP1855651A4 (en) * | 2005-03-03 | 2011-06-15 | Elan Pharma Int Ltd | NANOPARTICULAR COMPOSITIONS OF HETEROCYCLIC AMIDE DERIVATIVES |
US20070197467A1 (en) * | 2006-02-06 | 2007-08-23 | Srinivasulu Rangineni | Zafirlukast compositions |
US20090012146A1 (en) * | 2007-07-02 | 2009-01-08 | Giridhar Reddy Buggana | Solubility-enhanced pharmaceutical compositions comprising zafirlukast |
WO2009018280A2 (en) * | 2007-07-30 | 2009-02-05 | Auspex Pharamaceuticals, Inc. | Substituted indoles |
TWI469965B (zh) * | 2008-12-22 | 2015-01-21 | Ono Pharmaceutical Co | 乙炔基吲哚化合物 |
WO2014012954A1 (en) | 2012-07-18 | 2014-01-23 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma |
CN103396353B (zh) * | 2013-08-23 | 2015-05-20 | 海南通用三洋药业有限公司 | 一种扎鲁司特无定型态及其制备方法 |
JP2017503814A (ja) | 2014-01-22 | 2017-02-02 | タケダ ゲー・エム・ベー・ハーTakeda GmbH | 部分的コントロール状態の重症喘息またはコントロール不良状態の重症喘息のpde4インヒビターを用いた(およびロイコトリエン調節薬と組み合わせて用いた)治療 |
PT109030B (pt) * | 2015-12-15 | 2019-09-25 | Hovione Farmaciência, S.A. | Preparação de partículas inaláveis de zafirlucaste |
US11872210B2 (en) | 2017-01-30 | 2024-01-16 | Western New England University | Thiol isomerases inhibitors and use thereof |
US20220370401A1 (en) | 2021-05-19 | 2022-11-24 | Quercis Pharma AG | Method for treating amyotrophic lateral sclerosis using quercetin-containing compositions |
WO2023214391A1 (en) | 2022-05-06 | 2023-11-09 | Quercis Pharma AG | Method for treating cancers and neurological diseases using quercetin-containing compositions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4161516A (en) * | 1975-07-25 | 1979-07-17 | Fisons Limited | Composition for treating airway disease |
GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
-
1990
- 1990-12-12 GB GB909027018A patent/GB9027018D0/en active Pending
-
1991
- 1991-11-19 IL IL10009091A patent/IL100090A/en active IP Right Grant
- 1991-11-22 CA CA002056067A patent/CA2056067C/en not_active Expired - Fee Related
- 1991-12-06 TW TW080109583A patent/TW222264B/zh active
- 1991-12-09 HU HU913863A patent/HU213109B/hu not_active IP Right Cessation
- 1991-12-10 MX MX9102475A patent/MX9102475A/es not_active IP Right Cessation
- 1991-12-11 MY MYPI91002300A patent/MY108629A/en unknown
- 1991-12-11 ES ES91311505T patent/ES2094797T3/es not_active Expired - Lifetime
- 1991-12-11 DE DE69123123T patent/DE69123123T2/de not_active Expired - Lifetime
- 1991-12-11 PH PH43618A patent/PH30041A/en unknown
- 1991-12-11 RU SU5010266A patent/RU2107682C1/ru not_active IP Right Cessation
- 1991-12-11 AT AT91311505T patent/ATE145199T1/de not_active IP Right Cessation
- 1991-12-11 DK DK91311505.1T patent/DK0490649T3/da active
- 1991-12-11 EP EP91311505A patent/EP0490649B1/en not_active Expired - Lifetime
- 1991-12-11 GB GB9126353A patent/GB2250743B/en not_active Expired - Lifetime
- 1991-12-11 AU AU88995/91A patent/AU656344B2/en not_active Ceased
- 1991-12-11 US US07/805,426 patent/US5294636A/en not_active Expired - Lifetime
- 1991-12-11 IE IE431691A patent/IE914316A1/en not_active IP Right Cessation
- 1991-12-11 SK SK3758-91A patent/SK279018B6/sk unknown
- 1991-12-11 CZ CS19913758A patent/CZ288151B6/cs not_active IP Right Cessation
- 1991-12-11 ZA ZA919772A patent/ZA919772B/xx unknown
- 1991-12-11 NZ NZ240940A patent/NZ240940A/en not_active IP Right Cessation
- 1991-12-11 AP APAP/P/1991/000341A patent/AP286A/en active
- 1991-12-11 FI FI915825A patent/FI101296B1/fi not_active IP Right Cessation
- 1991-12-11 JP JP3327439A patent/JP2650807B2/ja not_active Expired - Lifetime
- 1991-12-11 CN CN91112791A patent/CN1032469C/zh not_active Expired - Fee Related
- 1991-12-11 KR KR1019910022609A patent/KR100194479B1/ko not_active IP Right Cessation
-
1995
- 1995-06-15 HU HU95P/P00208P patent/HU211125A9/hu unknown
- 1995-08-30 CN CN95115922A patent/CN1074411C/zh not_active Expired - Fee Related
-
1996
- 1996-11-14 GR GR960402814T patent/GR3021605T3/el unknown
-
1997
- 1997-06-19 HK HK81497A patent/HK81497A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI101296B1 (fi) | Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi | |
FI101193B1 (fi) | Menetelmä N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidin fysikaalista muotoa sisältävän farmaseuttisen koostumuksen valmistamiseksi | |
IL126674A (en) | Use of cyclic and heterocyclic compounds for preparing pharmaceutical compositions inhibiting impdh activity, pharmaceutical compositions containing the same and novel thiazole and oxazole urea derivatives | |
ZA925573B (en) | 5-membered heterocyclic compounds processes for preparing them and pharmaceutical compositions containing these compounds | |
NO933093L (no) | Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2H-indol-2-on hydroklorid | |
MY131288A (en) | Pyrazole carboxanilide fungicides | |
FI950383A0 (fi) | Uusi menetelmä kiraalisen (((2-bromietyyli)amino)metyyli)-2-nitro-1H-imidatsoli-1-etanolin ja sen sukuisten yhdisteiden valmistamiseksi | |
NZ229410A (en) | Stable injectable pharmaceutical composition containing methyl 3-(4-(2-hydroxy-3-isopropylamino)propoxy) phenyl propionate hydrochloride (esmolol) | |
NO894845D0 (no) | Fremgangsmaate og materialer for mikrobiell bioomdannelse av toluen og andre fenylforbindelser. | |
FI913554A (fi) | Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi | |
IL44874A (en) | Compositions for regulating plant growth, containing n-(3-(methyl-thio)propyl) ureas or 5-(methyl-thioethyl)-hydantoins and certain novel compounds of these types | |
EP0006564A3 (en) | 2-(3.5-disubstituted-2-hydroxyphenyl)-2h-benzotriazoles, stabilized compositions containing them and method for preparing azo compounds as starting materials for the benzotriazoles | |
DK0615971T3 (da) | 5-(Piperazinylalkyl)-1,5-benzothiazepinoner, der kan anvendes som calciumantagonister | |
IL56513A (en) | 3-(n-(acyloxyacetyl)-n-(substituted phenyl))-aminotetrahydro-2-furanone derivatives,their production and microbicidal compositions containing them | |
DK527585A (da) | Monoethanolaminsaltet af n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxid paa saerlig krystallinsk form | |
NZ191067A (en) | 2-(n-allyl-n-(substituted phenyl) amino)-2-imidazoline derivatives pharmaceutical compositions | |
BG43682A3 (en) | Herbicide composition and method for control of unwanted vegetation | |
NO179575C (no) | Farmasöytisk preparat inneholdende en fysikalsk form av forbindelsen N-[4-[5-(cyklopentyloksykarbonyl)amino-1-metylindol-3-ylmetyl-3-metoksybenzoylÅ-2-metylbenzensulfonamid | |
HU911239D0 (en) | Process for producing 4-[3-(4-oxo-thiazolidinyl)]-1-butinyl-amine derivatives and pharmaceutical preparatives containing said compounds as active substance | |
PH19228A (en) | N-(2-(((5-dimethylamino)-methyl-2-furanyl)-methyl)-thio)-ethyl)-n'(3,4-methylenedioxybenzyl)-2-nitro-1,1-ethenediamine,process for the preparation thereof and pharmaceutical composition thereof | |
MX9202715A (es) | Nuevos derivados de oxazol y proceso para su preparacion. | |
NO960116D0 (no) | Fremgangsmåte for fremstilling av en fysikalsk form av N-[4-[5-(cyklopentyloksykarbonyl)amino-1-metylindol-3-ylmetylÅ-3-metoksybenzoylÅ-2-metylbenzensulfonamid | |
FI972528A0 (fi) | Menetelmä N-(4-(5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli)-3-metoksibentsoyyli)-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi | |
IT1188307B (it) | Ribaltatore per impianti di imballaggio di materiali pallettizzabili | |
NO179248C (no) | Fysikalsk form av N-[4-[5-(cyklopentyloksykarbonyl)amino-1-metylindol-3-ylmetylÅ-3-metoksybenzoylÅ-2-metylbenzensulfonamid og fremgangsmåte for fremstilling derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Owner name: ZENECA LIMITED |
|
GB | Transfer or assigment of application |
Owner name: ZENECA LIMITED |
|
MA | Patent expired |